HCPCS Codes Similar to G0567

HCPCS Codes Similar to “G0567” Code.
Infectious agent detection by nucleic acid (dna or rna); hepatitis c, screening, amplified probe technique

U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r Code added date: 20200414 Code effective date: 20230512 TXT \| PDF \| XML \| JSON	U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 Code added date: 20210101 Code effective date: 20230512 TXT \| PDF \| XML \| JSON
G0476 Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test Code added date: 20150709 Code effective date: 20150709 TXT \| PDF \| XML \| JSON	G0432 Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening Code added date: 20091208 Code effective date: 20101001 TXT \| PDF \| XML \| JSON
G0433 Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening Code added date: 20091208 Code effective date: 20130101 TXT \| PDF \| XML \| JSON	G0435 Infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2, screening Code added date: 20091208 Code effective date: 20101001 TXT \| PDF \| XML \| JSON
M1368 Prevention and treatment of infectious disorders including hepatitis c and hiv mips value pathway Code added date: 20240101 Code effective date: 20240101 TXT \| PDF \| XML \| JSON	G0545 Visit complexity inherent to hospital inpatient or observation care associated with a confirmed or suspected infectious disease by an infectious diseases specialist, including disease transmission risk assessment and mitigation, public health investigation, analysis, and testing, and complex antimicrobial therapy counseling and treatment (add-on code, list separately in addition to hospital inpatient or observation evaluation and management visit, initial, same day discharge, subsequent or discharge) Code added date: 20250101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON
G4010 Infectious disease mips specialty set Code added date: 20220101 Code effective date: 20220101 TXT \| PDF \| XML \| JSON	M1184 Documentation of medical reason(s) for not prescribing or administering corticosteroid or immunosuppressant treatment (e.g., allergy, intolerance, infectious etiology, pancreatic insufficiency, hyperthyroidism, prior bowel surgical interventions, celiac disease, receiving other medication, awaiting diagnostic workup results for alternative etiologies, other medical reasons/contraindication) Code added date: 20230101 Code effective date: 20230101 TXT \| PDF \| XML \| JSON
G0464 Colorectal cancer screening; stool-based dna and fecal occult hemoglobin (e.g., kras, ndrg4 and bmp3) Code added date: 20141009 Code effective date: 20160101 TXT \| PDF \| XML \| JSON	S3890 Dna analysis, fecal, for colorectal cancer screening Code added date: 20040401 Code effective date: 20160101 TXT \| PDF \| XML \| JSON
G8460 Clinician documented that patient is not an eligible candidate for quantitative rna testing at week 12; patient not receiving antiviral treatment for hepatitis c Code added date: 20080101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON	G9203 Rna testing for hepatitis c documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c Code added date: 20140101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON